# Fructose-sweetened beverages induce diurnal redox dysregulation in pediatric MASLD

**Authors:** Helaina E. Huneault, Scott E. Gillespie, Zachery R. Jarrell, Shasha Bai, Ana Ramirez Tovar, Cristian Sanchez-Torres, Lucia A. Gonzalez-Ramirez, Kelsey C. Chatman, Thomas R. Ziegler, Dean P. Jones, Jean A. Welsh, Miriam B. Vos

PMC · DOI: 10.1016/j.redox.2026.104012 · Redox Biology · 2026-01-08

## TL;DR

This study shows that drinking fructose-sweetened beverages increases oxidative stress in children with a liver condition called MASLD, more so than glucose-sweetened drinks.

## Contribution

The study is the first to show fructose's impact on redox imbalance in children with MASLD, revealing a potential therapeutic target.

## Key findings

- Plasma redox states vary diurnally in children and are more oxidized in those with MASLD.
- Fructose intake increases oxidation of the GSH/GSSG redox couple and lowers GSH levels overnight in MASLD.
- Fructose is identified as a driver of redox imbalance in pediatric MASLD.

## Abstract

Plasma glutathione/glutathione disulfide (GSH/GSSG) and cysteine/cystine (Cys/CySS) redox couples undergo diurnal variation in adults and are more oxidized in obesity-related conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD). There is limited research on redox in children and no data on redox responses to sugars, despite high sugar consumption in this population. This study aimed to describe the diurnal variation of redox couples in children, assess the impact of MASLD, and evaluate responses to fructose versus glucose beverages.

In a 2-day randomized, controlled, crossover feeding study, 26 children (12 with MASLD, 14 controls; aged 10–18 years) consumed isocaloric meals with fructose beverages (FB) on one day and glucose beverages (GB) (set as control) on another, following a washout period. Blood was collected every 2 h over 24 h and analyzed for Cys/CySS and GSH/GSSG. Redox potentials, Eh(Cys/CySS) and Eh(GSH/GSSG), were calculated using the Nernst equation. Linear mixed models assessed diurnal variation and effects of MASLD and beverage type.

Plasma Eh(GSH/GSSG) and Eh(CyS/CySS) varied significantly over time after both FB and GB (p < 0.05). With FB, Eh(GSH/GSSG) was significantly more oxidized in children with MASLD (p = 0.034); this was not observed with GB. Among children with MASLD, FB also led to greater Eh(GSH/GSSG) oxidation and lower GSH levels overnight (p < 0.05). While Eh(Cys/CySS) showed a similar trend, differences did not reach statistical significance.

Our findings demonstrate that plasma redox states vary diurnally in children and are more oxidized in those with MASLD. Fructose intake increased oxidation of the GSH/GSSG redox couple and lowered GSH concentrations overnight, indicating heightened oxidative stress. These results identify fructose as a driver of redox imbalance in pediatric MASLD and support fructose reduction and glutathione restoration as therapeutic targets.

Image 1

•Plasma redox couples (Cys/CySS, GSH/GSSG) show diurnal variation in children.•Children with MASLD display more oxidized plasma redox states across the day.•Fructose intake increases oxidation of the GSH/GSSG redox couple in MASLD.•Lower overnight GSH suggests decreased antioxidant capacity after fructose intake.•Findings highlight fructose as a driver of redox imbalance in pediatric MASLD.

Plasma redox couples (Cys/CySS, GSH/GSSG) show diurnal variation in children.

Children with MASLD display more oxidized plasma redox states across the day.

Fructose intake increases oxidation of the GSH/GSSG redox couple in MASLD.

Lower overnight GSH suggests decreased antioxidant capacity after fructose intake.

Findings highlight fructose as a driver of redox imbalance in pediatric MASLD.

## Linked entities

- **Chemicals:** fructose (PubChem CID 5984), glucose (PubChem CID 5793), glutathione (PubChem CID 124886), GSH (PubChem CID 124886), GSSG (PubChem CID 65359), cysteine (PubChem CID 594), cystine (PubChem CID 67678)
- **Diseases:** MASLD (MONDO:0013209), metabolic dysfunction-associated steatotic liver disease (MONDO:0013209)

## Full-text entities

- **Diseases:** obesity (MESH:D009765), MASLD (MESH:D008107)
- **Chemicals:** CySS (-), Fructose (MESH:D005632), CyS (MESH:D003545), glucose (MESH:D005947), sugar (MESH:D000073893), GSH (MESH:D005978), GSSG (MESH:D019803), cystine (MESH:D003553), disulfide (MESH:D004220)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12830102/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12830102/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12830102/full.md

---
Source: https://tomesphere.com/paper/PMC12830102